ICO
Closed:
Breakthrough Therapies & Innovative Models for Kidney Diseases
Galapagos is a commercial-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos is seeking research focused on kidney diseases such as chronic kidney diseases including polycystic kidney disease (PCKD), diabetic kidney disease and Alport syndrome.
Targets and Therapeutic Interventions
- Research focusing on novel MoA/pathways/targets involved in kidney diseases: Reducing tubular atrophy & interstitial inflammation and fibrosis; Preserving glomerular filtration by making ...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile